Adc Therapeutics Sa
(ADCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 300,119 | 234,285 | 278,598 | 310,407 | 347,510 |
| Receivables | 22,868 | 23,186 | 25,182 | 21,180 | 23,866 |
| Inventories | 15,191 | 15,997 | 16,177 | 22,728 | 19,428 |
| Other current assets | 17,181 | 16,738 | 5,990 | 21,283 | 22,004 |
| TOTAL | $355,359 | $290,206 | $336,291 | $375,598 | $412,808 |
| Non-Current Assets | |||||
| PPE Net | 5,483 | 5,785 | 5,622 | 5,260 | 5,400 |
| Investments And Advances | 260 | 930 | 1,647 | 26,989 | 28,322 |
| Intangibles | 0 | 0 | 0 | 12,358 | 13,536 |
| Other Non-Current Assets | 10,677 | 11,045 | 11,222 | 46,695 | 47,236 |
| TOTAL | $16,420 | $17,760 | $18,491 | $91,302 | $94,494 |
| Total Assets | $371,779 | $307,966 | $354,782 | $466,900 | $507,302 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 14,329 | 13,861 |
| Accounts payable and accrued liabilities | 10,708 | 14,315 | 15,569 | 8,977 | 11,691 |
| Accrued Expenses | 46,924 | 48,670 | 52,101 | N/A | N/A |
| Other current liabilities | N/A | N/A | N/A | 53,483 | 53,397 |
| TOTAL | $57,632 | $62,985 | $67,670 | $78,206 | $80,581 |
| Non-Current Liabilities | |||||
| Long Term Debt | 113,673 | 113,234 | 112,730 | 97,707 | 97,356 |
| Other Non-Current Liabilities | 332,144 | 326,196 | 322,631 | 345,168 | 337,954 |
| TOTAL | $445,817 | $439,430 | $435,361 | $442,875 | $435,310 |
| Total Liabilities | $503,449 | $502,415 | $503,031 | $521,081 | $515,891 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,647 | 82,814 | N/A | N/A | N/A |
| Common Shares | 8,233 | 7,312 | 7,312 | 7,312 | 7,312 |
| Retained earnings | -1,418,622 | -1,382,078 | -1,335,472 | -1,235,035 | -1,187,228 |
| Other shareholders' equity | -577 | 297 | 366 | 166,454 | 164,572 |
| TOTAL | $-131,670 | $-194,449 | $-148,249 | $-54,181 | $-8,589 |
| Total Liabilities And Equity | $371,779 | $307,966 | $354,782 | $466,900 | $507,302 |